Class USE Stem Cell Patents

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Treatment Patents for USE Class

Adeno-associated viral (AAV) liposomes and methods related thereto
U.S. Patent: 5861314, Published: 1/19/1999

Adeno-associated viral (AAV) liposomes and methods related thereto
U.S. Patent: 5861171, Published: 1/19/1999

Adeno-associated viral (AAV) liposomes and methods related thereto
U.S. Patent: 5834441, Published: 11/10/1998

Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
U.S. Patent: 7078232, Published: 7/18/2006

Administration of an RNA stem loop structure to modulate protein synthesis
U.S. Patent: 5593863, Published: 1/14/1997

Allelic series of genomic modifications in cells
U.S. Patent: 6835867, Published: 12/28/2004

Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
U.S. Patent: 6143292, Published: 11/7/2000

A-myb null mutant transgenic mice
U.S. Patent: 6410825, Published: 6/25/2002

Animal model for engraftment, proliferation and differentiation of human hematopoietic stem cells
U.S. Patent: 6018096, Published: 1/25/2000

Apparatus for enhanced plasmapheresis and methods thereof
U.S. Patent: 6960178, Published: 11/1/2005

Arenavirus receptor and methods of use
U.S. Patent: 6083911, Published: 7/4/2000

Assay to detect the presence of live non-A, non-B hepatitis agents in vitro
U.S. Patent: 4952494, Published: 8/28/1990

Assay to detect the presence of live virus in vitro
U.S. Patent: 5073481, Published: 12/17/1991

Bacterial cell component-unresponsive model mouse
U.S. Patent: 7078585, Published: 7/18/2006

Basolateral sorting signal and inhibitors thereof
U.S. Patent: 7033794, Published: 4/25/2006

Biological material containing bone marrow stem cells partially or completely differentiated into connective tissue cells and a hyaluronic acid ester matrix
U.S. Patent: 6596274, Published: 7/22/2003

Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
U.S. Patent: 6482231, Published: 11/19/2002

Biosynthetic gene murD from streptococcus pneumoniae
U.S. Patent: 5834270, Published: 11/10/1998

Biosynthetic gene murg from streptococcus pneumoniae
U.S. Patent: 5821335, Published: 10/13/1998

Biosynthetic gene muri from Streptococcus pneumoniae
U.S. Patent: 5948645, Published: 9/7/1999

Bone marrow transplantation
U.S. Patent: 5806529, Published: 9/15/1998

Cap-independent multicistronic retroviral vectors
U.S. Patent: 6319707, Published: 11/20/2001

Cardiac muscle regeneration using mesenchymal stem cells
U.S. Patent: 6387369, Published: 5/14/2002

CD45 disrupted nucleic acid
U.S. Patent: 6664107, Published: 12/16/2003

Cell compositions for use in transplantation
U.S. Patent: 6068836, Published: 5/30/2000

Cell lines and methods for screening growth regulatory compounds
U.S. Patent: 5741646, Published: 4/21/1998

Cells and methods for the generation of transgenic pigs
U.S. Patent: 6271436, Published: 8/7/2001

Chimeric chains for receptor-associated signal transduction pathways
U.S. Patent: 6319494, Published: 11/20/2001

Chimeric chains for receptor-associated signal transduction pathways
U.S. Patent: 6407221, Published: 6/18/2002

Composite bone marrow graft material with method and kit
U.S. Patent: 6723131, Published: 4/20/2004

Composition and method for treating graft-versus-host disease
U.S. Patent: 7037900, Published: 5/2/2006

Composition comprising multipotent neural stem cells for generation of hematopoietic cells
U.S. Patent: 6897060, Published: 5/24/2005

Composition for treating cornea
U.S. Patent: 5942487, Published: 8/24/1999

Compositions and methods for non-targeted activation of endogenous genes
U.S. Patent: 6410266, Published: 6/25/2002

Compositions and methods for non-targeted activation of endogenous genes
U.S. Patent: 6361972, Published: 3/26/2002

Compositions containing cultured mitotic human stem cells
U.S. Patent: 5670147, Published: 9/23/1997

Compound screening assays using a transgenic mouse model of human skin diseases
U.S. Patent: 6576812, Published: 6/10/2003

Compounds useful for the treatment of cancer, compositions thereof and methods therewith
U.S. Patent: 7037936, Published: 5/2/2006

Computer-based mixed-use registry of placental and umbilical cord stem cells
U.S. Patent: 5993387, Published: 11/30/1999

Connective tissue regeneration using human mesenchymal stem cell preparations
U.S. Patent: 5811094, Published: 9/22/1998

Costimulatory blockade and mixed chimerism in allo-transplantation
U.S. Patent: 6280957, Published: 8/28/2001

Costimulatory blockade and mixed chimerism in transplantation
U.S. Patent: 6514513, Published: 2/4/2003

Delivery construct for antisense nucleic acids and methods of use
U.S. Patent: 5814500, Published: 9/29/1998

Delivery construct for antisense nucleic acids and methods of use
U.S. Patent: 6924096, Published: 8/2/2005

Delivery of therapeutic biologicals from implantable tissue matrices
U.S. Patent: 7078032, Published: 7/18/2006

Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
U.S. Patent: 5985276, Published: 11/16/1999

Dual resonance energy transfer nucleic acid probes
U.S. Patent: 7081336, Published: 7/25/2006

Efficient construction of gene targeting using phage-plasmid recombination
U.S. Patent: 6090629, Published: 7/18/2000

Efficient construction of gene targeting vectors
U.S. Patent: 6090554, Published: 7/18/2000

Efficient method for production of compound transgenic animals
U.S. Patent: 6281408, Published: 8/28/2001

Enhanced virus-mediated DNA transfer
U.S. Patent: 6033907, Published: 3/7/2000

Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
U.S. Patent: 6010696, Published: 1/4/2000

Erythropoietin-inducible, erythroid-specific DNA construct
U.S. Patent: 6153427, Published: 11/28/2000

Gene delivery vectors with cell type specificity for mesenchymal stem cells
U.S. Patent: 6905678, Published: 6/14/2005

Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
U.S. Patent: 7049072, Published: 5/23/2006

Gene therapy by cell specific targeting
U.S. Patent: 6982082, Published: 1/3/2006

Gene therapy for Gaucher disease using retroviral vectors
U.S. Patent: 5911983, Published: 6/15/1999

Gene therapy using the intestine
U.S. Patent: 5821235, Published: 10/13/1998

Gene transfer in chicken bursal stem cells
U.S. Patent: 6946266, Published: 9/20/2005

Gene transfer to the intestine
U.S. Patent: 5786340, Published: 7/28/1998

Gene trap construct for identification and isolation of genes
U.S. Patent: 6303327, Published: 10/16/2001

Gene trap vectors
U.S. Patent: 6248934, Published: 6/19/2001

Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
U.S. Patent: 6605710, Published: 8/12/2003

Generation of xenogeneic antibodies
U.S. Patent: 6114598, Published: 9/5/2000

Generation of xenogeneic antibodies
U.S. Patent: 6673986, Published: 1/6/2004

Generation of Xenogenetic antibodies
U.S. Patent: 6162963, Published: 12/19/2000

Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring
U.S. Patent: 6284944, Published: 9/4/2001

Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
U.S. Patent: 6734336, Published: 5/11/2004

Genetic engineering of cells to enhance healing and tissue regeneration
U.S. Patent: 6077987, Published: 6/20/2000

Genetic engineering of cells to enhance healing and tissue regeneration
U.S. Patent: 6398816, Published: 6/4/2002

Genetic modification of C57 mice
U.S. Patent: 7132282, Published: 11/7/2006

Genetically engineered mammals for use as organ donors
U.S. Patent: 6331658, Published: 12/18/2001

Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
U.S. Patent: 6486381, Published: 11/26/2000

Glutathione S-transferase-activated compounds
U.S. Patent: 5556942, Published: 9/17/1996

Hematopoietic cell composition for use in transplantation
U.S. Patent: 7101708, Published: 9/5/2006

Hematopoietic cell method for treatment of HIV infection
U.S. Patent: 6365404, Published: 4/2/2002

Hematopoietic cell method for treatment of HIV infection
U.S. Patent: 6271028, Published: 8/7/2001

Hematopoietic stem cell specific gene expression
U.S. Patent: 5556954, Published: 9/17/1996

High efficiency gene trap selection of regulated genetic loci
U.S. Patent: 5922601, Published: 7/13/1999

High throughput gene inactivation with large scale gene targeting
U.S. Patent: 6069010, Published: 5/30/2000

Highly efficient gene transfer into human repopulating stem cells by RD114 pseudotyped retroviral vector particles
U.S. Patent: 6849454, Published: 2/1/2005

HIV-MSCV hybrid viral vector for gene transfer
U.S. Patent: 6218186, Published: 4/17/2001

Human antibodies derived from immunized xenomice
U.S. Patent: 6713610, Published: 3/30/2004

Human antibodies derived from immunized xenomice
U.S. Patent: 6150584, Published: 11/21/2000

Human antibodies derived from immunized xenomice
U.S. Patent: 6075181, Published: 6/13/2000

Human antibodies derived from immunized xenomice
U.S. Patent: 6657103, Published: 12/2/2003

Human gene/protein involved in chronic myelogenous leukemia
U.S. Patent: 6100386, Published: 8/8/2000

Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors
U.S. Patent: 5489516, Published: 2/6/1996

Immune cell cytokine
U.S. Patent: 6537539, Published: 3/25/2003

Immunosuppressive agents
U.S. Patent: 6531505, Published: 3/11/2003

Immunotherapy of cancer with allogeneic lymphocytes
U.S. Patent: 5928639, Published: 7/27/1999

Immunotherapy of cancer with allogeneic lymphocytes
U.S. Patent: 5843435, Published: 12/1/1998

In vitro test for embryotoxic and teratogenic agents using differentiation-dependent reporter expression in pluripotent rodent embryonic cells
U.S. Patent: 6007993, Published: 12/28/1999

In vivo production and delivery of erythropoietin
U.S. Patent: 6355241, Published: 3/12/2002

In vivo production and delivery of erythropoietin for gene therapy
U.S. Patent: 6048524, Published: 4/11/2000

In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy
U.S. Patent: 6846676, Published: 1/25/2005

In vivo protein production and delivery system for gene therapy
U.S. Patent: 6692737, Published: 2/17/2004

In vivo protein production and delivery system for gene therapy
U.S. Patent: 6054288, Published: 4/25/2000

In vivo screening methods using enriched neural stem cells
U.S. Patent: 7105150, Published: 9/12/2006

Induced tolerance to xenografts
U.S. Patent: 6296846, Published: 10/2/2001

Inducible HSV-TK in transformed cell populations
U.S. Patent: 6677311, Published: 1/13/2004

Infusion of neutrophil precursors for treatment of neutropenia
U.S. Patent: 6010697, Published: 1/4/2000

Infusion of neutrophil precursors for treatment of neutropenia
U.S. Patent: 5846529, Published: 12/8/1998

Inhibition of HIV replication using a mutated transfer RNA primer
U.S. Patent: 6355790, Published: 3/12/2002

Interleukin-2 receptor deficient mammals
U.S. Patent: 5532158, Published: 7/2/1996

Introduction of HIV-protective genes into cells by particle-mediated gene transfer
U.S. Patent: 5733543, Published: 3/31/1998

I-Sce I induced gene replacement and gene conversion in embryonic stem cells
U.S. Patent: 6566579, Published: 5/20/2003

Knockout mice and their progeny with a disrupted hepsin gene
U.S. Patent: 5981830, Published: 11/9/1999

Knockout mouse for the tumor suppressor gene ANX7
U.S. Patent: 6747187, Published: 6/8/2004

Ku deficient cells and non-human transgenic animals
U.S. Patent: 5955644, Published: 9/21/1999

Lineage restricted glial precursors from the central nervous system
U.S. Patent: 6235527, Published: 5/22/2001

Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
U.S. Patent: 6455756, Published: 9/24/2002

Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor
U.S. Patent: 5948640, Published: 9/7/1999

Mammalian myeloid progenitor cell subsets
U.S. Patent: 6465247, Published: 10/15/2002

Materials and procedures for the purification of cells
U.S. Patent: 7015034, Published: 3/21/2006

Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight
U.S. Patent: 6639123, Published: 10/28/2003

Mesenchymal stem cells as immunosuppressants
U.S. Patent: 6797269, Published: 9/28/2004

Mesenchymal stem cells for cartilage repair
U.S. Patent: 6214369, Published: 4/10/2001

Mesenchymal stem cells for cartilage repair
U.S. Patent: 5906934, Published: 5/25/1999

Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
U.S. Patent: 6368636, Published: 4/9/2002

Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
U.S. Patent: 6328960, Published: 12/11/2001

Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
U.S. Patent: 6875430, Published: 4/5/2005

Method and apparatus for treating osteochondral pathologies
U.S. Patent: 6440141, Published: 8/27/2002

Method and oligonucleobase compounds for curing diseases caused by mutations
U.S. Patent: 5888983, Published: 3/30/1999

Method for developing transgenic mice
U.S. Patent: 6492575, Published: 12/10/2002

Method for gene transfer into target cells with retrovirus
U.S. Patent: 6949623, Published: 9/27/2005

Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
U.S. Patent: 5888499, Published: 3/30/1999

Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
U.S. Patent: 6051427, Published: 4/18/2000

Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
U.S. Patent: 5858740, Published: 1/12/1999

Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
U.S. Patent: 5834256, Published: 11/10/1998

Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
U.S. Patent: 6506604, Published: 1/14/2003

Method for transplantation of hemopoietic stem cells
U.S. Patent: 6383481, Published: 5/7/2002

Method of cloning animals
U.S. Patent: 6603059, Published: 8/5/2003

Method of cloning porcine animals
U.S. Patent: 6700037, Published: 3/2/2004

Method of cloning porcine animals
U.S. Patent: 6258998, Published: 7/10/2001

Method of constructing vectors for homologous recombination directed mutagenesis
U.S. Patent: 6924146, Published: 8/2/2005

Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantation
U.S. Patent: 6225051, Published: 5/1/2001

Method of gene transfer into chickens and other avian species
U.S. Patent: 5162215, Published: 11/10/1992

Method of identifying and modulating the activity of label retaining cells in hair follicles for diagnostic and therapeutic purposes
U.S. Patent: 5279969, Published: 1/18/1994

Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
U.S. Patent: 7138144, Published: 11/21/2006

Method of making transgenic mice lacking endogenous heavy chains
U.S. Patent: 5939598, Published: 8/17/1999

Method of pre-inducing a state of immune tolerance before organ transplantation
U.S. Patent: 6923959, Published: 8/2/2005

Method of preparing human stem cell factor polypeptide
U.S. Patent: 6759215, Published: 7/6/2004

Method of producing a mouse suitable for the engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse
U.S. Patent: 7145055, Published: 12/5/2006

Method of producing a polypeptide in an ungulate
U.S. Patent: 6395958, Published: 5/28/2002

Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
U.S. Patent: 5340740, Published: 8/23/1994

Method of producing clonal cell strains which express exogenous DNA encoding glucagon-like peptide 1
U.S. Patent: 6048724, Published: 4/11/2000

Method of producing mutant mice
U.S. Patent: 6784336, Published: 8/31/2004

Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
U.S. Patent: 5906938, Published: 5/25/1999

Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
U.S. Patent: 6866843, Published: 3/15/2005

Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
U.S. Patent: 5649904, Published: 7/22/1997

Methods and compositions for multiple gene transfer into bone cells
U.S. Patent: 5942496, Published: 8/24/1999

Methods and compositions for neural progenitor cells
U.S. Patent: 6890724, Published: 5/10/2005

Methods and compositions for preparing a genomic library for knockout targeting vectors
U.S. Patent: 6503712, Published: 1/7/2003

Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
U.S. Patent: 5928888, Published: 7/27/1999

Methods and compositions for transforming cells
U.S. Patent: 6534314, Published: 3/18/2003

Methods and compositions for transforming dendritic cells and activating T cells
U.S. Patent: 6734014, Published: 5/11/2004

Methods and compounds for curing diseases caused by mutations
U.S. Patent: 5760012, Published: 6/2/1998

Methods and vector constructs for making non-human animals which ubiquitously express a heterologous gene
U.S. Patent: 6461864, Published: 10/8/2002

Methods comprising apoptosis inhibitors for the generation of transgenic pigs
U.S. Patent: 6369294, Published: 4/9/2002

Methods for assaying gene imprinting and methylated CpG islands
U.S. Patent: 6960434, Published: 11/1/2005

Methods for diagnosis and treatment of Bloom's syndrome
U.S. Patent: 6221643, Published: 4/24/2001

Methods for enhanced retrovirus-mediated gene transfer
U.S. Patent: 5686278, Published: 11/11/1997

Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
U.S. Patent: 6670177, Published: 12/30/2003

Methods for enhancing angiogenesis with endothelial progenitor cells
U.S. Patent: 5980887, Published: 11/9/1999

Methods for gene transfer
U.S. Patent: 5928638, Published: 7/27/1999

Methods for inhibiting cutaneous inflammation and hyperpigmentation
U.S. Patent: 6977159, Published: 12/20/2005

Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
U.S. Patent: 5614396, Published: 3/25/1997

Methods of creating constructs useful for introducing sequences into embryonic stem cells
U.S. Patent: 6815185, Published: 11/9/2004

Methods of screening biological agents
U.S. Patent: 7101709, Published: 9/5/2006

Methods of using Flt-3 ligand for exogenous gene transfer
U.S. Patent: 6190655, Published: 2/20/2001

Methods to increase white blood cell survival after chemotherapy
U.S. Patent: 6475988, Published: 11/5/2002

Mice and cells with a homozygous disruption in the RNase L gene and methods therefore
U.S. Patent: 6028243, Published: 2/22/2000

Mice homozygous for an inactivated .alpha. 1,3-galactosyl transferase gene
U.S. Patent: 5849991, Published: 12/15/1998

Miniaturized cell array methods and apparatus for cell-based screening
U.S. Patent: 6548263, Published: 4/15/2003

Mouse having a disrupted CD4 gene
U.S. Patent: 5698765, Published: 12/16/1997

Mouse with defective endotheline-1 gene function
U.S. Patent: 5750825, Published: 5/12/1998

Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells
U.S. Patent: 6497875, Published: 12/24/2002

Multipotent neural stem cell cDNA libraries
U.S. Patent: 7105342, Published: 9/12/2006

Muri protein from Streptococcus pneumoniae
U.S. Patent: 6171834, Published: 1/9/2001

Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
U.S. Patent: 6866842, Published: 3/15/2005

Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1)
U.S. Patent: 5731490, Published: 3/24/1998

Mutant RAG-1 deficient animals having no mature B and T lymphocytes
U.S. Patent: 5859307, Published: 1/12/1999

Neural transplantation using proliferated multipotent neural stem cells and their progeny
U.S. Patent: 6497872, Published: 12/24/2002

Neurotrophin-3-deficient embryonic stem cells and mice and their use
U.S. Patent: 5625123, Published: 4/29/1997

Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation
U.S. Patent: 6544787, Published: 4/8/2003

Nuclear targeted peptide nucleic acid oligomer
U.S. Patent: 6312956, Published: 11/6/2001

Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
U.S. Patent: 6635802, Published: 10/21/2003

Nucleic acids of the bloom's syndrome gene
U.S. Patent: 5824501, Published: 10/20/1998

Peptidoglycan biosynthetic gene mur a from Strepococcus pneumoniae
U.S. Patent: 5770415, Published: 6/23/1998

Peptidoglycan biosynthetic gene murE from Streptococcus pneumoniae
U.S. Patent: 5821096, Published: 10/13/1998

Peptidoglycan biosynthetic mura protein from Streptococcus pneumoniae
U.S. Patent: 5691161, Published: 11/25/1997

Peptidoglycan biosynthetic mure protein from streptocuccus pneumoniae
U.S. Patent: 5712108, Published: 1/27/1998

Pharmaceutical products comprising endothelial cell precursors
U.S. Patent: 6569428, Published: 5/27/2003

Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors
U.S. Patent: 6969608, Published: 11/29/2005

Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ
U.S. Patent: 6991813, Published: 1/31/2006

Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene
U.S. Patent: 6849448, Published: 2/1/2005

Porcine Oct-4 promoter
U.S. Patent: 6482937, Published: 11/19/2002

Porcine stem cell factor varients and recombinant cells expressing such polypeptides
U.S. Patent: 6670151, Published: 12/30/2003

Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
U.S. Patent: 6638768, Published: 10/28/2003

Process for analyzing clastogenic agents
U.S. Patent: 5229265, Published: 7/20/1993

Process for detecting potential carcinogens
U.S. Patent: 6264915, Published: 7/24/2001

Production of proteins using homologous recombination
U.S. Patent: 5981214, Published: 11/9/1999

PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
U.S. Patent: 6909030, Published: 6/21/2005

Purified and isolated PIWI family genes and gene products and therapeutic and screening methods using same
U.S. Patent: 6723534, Published: 4/20/2004

Regeneration and augmentation of bone using mesenchymal stem cells
U.S. Patent: 6863900, Published: 3/8/2005

Regulatable retrovirus system for genetic modification of cells
U.S. Patent: 5770414, Published: 6/23/1998

Remedy for anemia and arthritis
U.S. Patent: 4767626, Published: 8/30/1988

Retroviral gene therapy vectors and therapeutic methods based thereon
U.S. Patent: 6544771, Published: 4/8/2003

Retroviral vector hybrids and the use thereof for gene transfer
U.S. Patent: 5858744, Published: 1/12/1999

Retroviral vector particles for transducing non-proliferating cells
U.S. Patent: 5580766, Published: 12/3/1996

Retroviral vector particles for transducing non-proliferating cells
U.S. Patent: 5576201, Published: 11/19/1996

Retroviral vectors for expression in embryonic cells
U.S. Patent: 5707865, Published: 1/13/1998

Screening method for controlling agranulocytosis
U.S. Patent: 5300422, Published: 4/5/1994

Sequence alterations using homologous recombination
U.S. Patent: 6200812, Published: 3/13/2001

Site-specific recombination in eukaryotes and constructs useful therefor
U.S. Patent: 7135608, Published: 11/14/2006

Specific tolerance in transplantation
U.S. Patent: 6306651, Published: 10/23/2001

Specific tolerance in transplantation
U.S. Patent: 5614187, Published: 3/25/1997

Storage system, particularly with automatic insertion and retrieval
U.S. Patent: 6564120, Published: 5/13/2003

Stress-regulated genes of plants, transgenic plants containing same, and methods of use
U.S. Patent: 7109033, Published: 9/19/2006

Synthetic ligation reassembly in directed evolution
U.S. Patent: 6605449, Published: 8/12/2003

Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
U.S. Patent: 5728521, Published: 3/17/1998

Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
U.S. Patent: 5624824, Published: 4/29/1997

Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
U.S. Patent: 5869248, Published: 2/9/1999

Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
U.S. Patent: 6214622, Published: 4/10/2001

Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production
U.S. Patent: 6537542, Published: 3/25/2003

Target-selective protocols based on mimics
U.S. Patent: 5786336, Published: 7/28/1998

T-cell receptors and their use in therapeutic and diagnostic methods
U.S. Patent: 5830755, Published: 11/3/1998

Tetracycline-regulated transcriptional inhibitors
U.S. Patent: 5789156, Published: 8/4/1998

Therapeutic and diagnostic compounds, compositions, and methods
U.S. Patent: 7115720, Published: 10/3/2006

Tissue filler
U.S. Patent: 7011829, Published: 3/14/2006

Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
U.S. Patent: 6313373, Published: 11/6/2001

T-lymphocyte progenitor cell assay
U.S. Patent: 5147784, Published: 9/15/1992

Transformed eukaryotic cells
U.S. Patent: 6156568, Published: 12/5/2000

Transgenic fish capable of expressing exogenous lytic peptides
U.S. Patent: 5998698, Published: 12/7/1999

Transgenic knockout animals lacking IgG3
U.S. Patent: 6080910, Published: 6/27/2000

TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR
U.S. Patent: 6485964, Published: 11/26/2002

Transgenic mice comprising CD45 knockout
U.S. Patent: 6552246, Published: 4/22/2003

Transgenic mice containing intestinal alkaline phosphatase gene disruptions
U.S. Patent: 6762342, Published: 7/13/2004

Transgenic mice depleted in a mature lymphocytic cell-type
U.S. Patent: 5591669, Published: 1/7/1997

Transgenic mice depleted in a mature lymphocytic cell-type
U.S. Patent: 6384298, Published: 5/7/2002

Transgenic mice depleted in mature T-cells and methods for making transgenic mice
U.S. Patent: 5175384, Published: 12/29/1992

Transgenic mice depleted in mature T-cells and methods for making transgenic mice
U.S. Patent: 5434340, Published: 7/18/1995

Transgenic mice exhibiting increased susceptibility to seizures
U.S. Patent: 6653526, Published: 11/25/2003

Transgenic mice with disrupted NPY Y1 receptor genes
U.S. Patent: 5817912, Published: 10/6/1998

Transgenic mouse deficient in inducible nitric oxide synthase
U.S. Patent: 5850004, Published: 12/15/1998

Transgenic mouse expressing non-native wild-type and familial Alzheimer's Disease mutant presenilin 1 protein on native presenilin 1 null background
U.S. Patent: 6452065, Published: 9/17/2002

Transgenic mouse for screening therapeutic agents for brain tumors
U.S. Patent: 7045678, Published: 5/16/2006

Transgenic murine model for XSCID
U.S. Patent: 5912173, Published: 6/15/1999

Transgenic non-human animals capable of producing heterologous antibodies
U.S. Patent: 5770429, Published: 6/23/1998

Transgenic non-human animals depleted in a mature lymphocytic cell-type
U.S. Patent: 6023010, Published: 2/8/2000

Transgenic non-human animals for producing heterologous antibodies
U.S. Patent: 5625126, Published: 4/29/1997

Transgenic non-human animals having targeting endogenous lymphocyte transduction genes and cognate human transgenes
U.S. Patent: 5859312, Published: 1/12/1999

Transgenic rats containing at least one human gene which participates in blood pressure control
U.S. Patent: 5731489, Published: 3/24/1998

Transgenic swine & swine cells having human HLA genes
U.S. Patent: 6558663, Published: 5/6/2003

Transgenic swine compositions and methods
U.S. Patent: 5523226, Published: 6/4/1996

Transgenic swine compositions and methods
U.S. Patent: 5942435, Published: 8/24/1999

Transgenic transchromosomal rodents for making human antibodies
U.S. Patent: 7041870, Published: 5/9/2006

Transgenic UCP2 knockout mouse and use thereof
U.S. Patent: 6365796, Published: 4/2/2002

Transgenic ungulate compositions and methods
U.S. Patent: 7071373, Published: 7/4/2006

Transplantation and graft-versus-host-disease
U.S. Patent: 5843425, Published: 12/1/1998

Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs
U.S. Patent: 6808702, Published: 10/26/2004

Treatment of HIV infections
U.S. Patent: 6800616, Published: 10/5/2004

Treatment of viral infections
U.S. Patent: 5077280, Published: 12/31/1991

Use of human embryonic stem cells for drug screening and toxicity testing
U.S. Patent: 7041438, Published: 5/9/2006

Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system
U.S. Patent: 7022321, Published: 4/4/2006

Use of multipotent neural stem cell progeny to augment non-neural tissues
U.S. Patent: 6638501, Published: 10/28/2003

Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
U.S. Patent: 6294346, Published: 9/25/2001

Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
U.S. Patent: 6818612, Published: 11/16/2004

Uses for non-autologous mesenchymal stem cells
U.S. Patent: 7029666, Published: 4/18/2006

Uses for non-autologous mesenchymal stem cells
U.S. Patent: 6355239, Published: 3/12/2002

Vector for integration site independent gene expression in mammalian host cells
U.S. Patent: 5859309, Published: 1/12/1999

Vector for integration site independent gene expression in mammalian host cells which permit immunoglobulin gene expression
U.S. Patent: 5770449, Published: 6/23/1998

Vectors and methods for the mutagenesis of mammalian genes
U.S. Patent: 6228639, Published: 5/8/2001

Vectors for gene mutagenesis and gene discovery
U.S. Patent: 6776988, Published: 8/17/2004

Vivo protein production and delivery system for gene therapy
U.S. Patent: 6303379, Published: 10/16/2001

Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
U.S. Patent: 7033781, Published: 4/25/2006

Yeast artificial chromosomes and their use in the control of gene expression
U.S. Patent: 6348349, Published: 2/19/2002

Yeast artificial chromosomes and their use in the control of gene expression
U.S. Patent: 5776773, Published: 7/7/1998



 
Copyright © 2007 The Institute for Cellular Medicine  10/17/2019